Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DDE-261: a novel gigantecin analogue in early development at Wayne Hughes Institute

Dec. 11, 1998

Novel topoisomerase inhibitor of microbial origin characterized at Kumamoto University

Dec. 11, 1998

Idec further defines clinical usage of IDEC-Y2B8

Dec. 10, 1998

ImClone's anti-KDR antibody, a novel angiogenesis inhibitor, featured at ASH

Dec. 10, 1998

New antitumor series developed at Daiichi

Dec. 10, 1998

Aronex files first NDA for orphan drug for APL

Dec. 9, 1998

Banyu conducts PK and metabolic studies of topoisomerase I inhibitor

Dec. 9, 1998

CoCensys patents key cell death gene, will license the technology out

Dec. 9, 1998

Preliminary report of therapeutic efficacy with 506U78 in leukemia patients

Dec. 8, 1998

Hughes Institute studying BTK-specific inhibitor LFM-A13

Dec. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...